{"id":95436,"date":"2026-07-01T17:18:43","date_gmt":"2026-07-01T17:18:43","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/95436\/"},"modified":"2026-07-01T17:18:43","modified_gmt":"2026-07-01T17:18:43","slug":"roche-targets-double-digit-market-share-in-weight-loss-aims-to-catch-up-with-novo-nordisk-handelsblatt-reports-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/95436\/","title":{"rendered":"Roche targets double-digit market share in weight loss, aims to catch up with Novo Nordisk, Handelsblatt reports"},"content":{"rendered":"<p>BERLIN, March 3 (Reuters) &#8211; Swiss pharmaceutical company \u200bRoche <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/ROG.S\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(ROG.S), opens new tab<\/a> is aiming \u200cfor a double-digit market share in \u200bthe weight \u200bloss market and wants \u2060to close \u200bthe gap on \u200bits Danish rival Novo Nordisk <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/NOVOb.CO\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(NOVOb.CO), opens new tab<\/a>, its CEO told \u200bGermany&#8217;s Handelsblatt \u200bbusiness daily.<\/p>\n<p>&#8220;We expect to \u200cbe \u2060among the top three in the market at \u200bthe \u200bvery \u2060least,&#8221; Roche Chief Executive \u200bThomas Schinecker said \u200bin \u2060an interview with the newspaper \u2060published \u200bon \u200bTuesday.<\/p>\n<p data-testid=\"promo-box\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf article-body-module__promo-box__hVl8h\"> Sign up  <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/roche-targets-double-digit-market-share-weight-loss-aims-catch-up-with-novo-2026-03-03\/undefined?location=article-paragraph&amp;redirectUrl=%2Fbusiness%2Fhealthcare-pharmaceuticals%2Froche-targets-double-digit-market-share-weight-loss-aims-catch-up-with-novo-2026-03-03%2F\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">here.<\/a><\/p>\n<p data-testid=\"SignOff\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__extra_small__8Buss body-module__full_width__kCIGb body-module__extra_small_body__Bfz20 sign-off-module__text__LQAMP\">Writing by Linda Pasquini; Editing \u200bby Christopher Cushing<\/p>\n<p data-testid=\"Body\" dir=\"ltr\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf article-body-module__element__5eCce article-body-module__trust-badge__5mS3f\">Our Standards: <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.thomsonreuters.com\/en\/about-us\/trust-principles.html\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__medium__2Rl30 text-module__small__sph8i link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">The Thomson Reuters Trust Principles., opens new tab<\/a><\/p>\n<p><a href=\"https:\/\/www.reutersagency.com\/en\/licensereuterscontent\/?utm_medium=rcom-article-media&amp;utm_campaign=rcom-rcp-lead\" target=\"_blank\" dir=\"ltr\" class=\"button-module__link__A3sD0 button-module__secondary__70gBu button-module__round__QDFgq button-module__w_auto__Sem-F\" data-testid=\"LicenceContentButton\" rel=\"nofollow noopener\">Purchase Licensing Rights<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"BERLIN, March 3 (Reuters) &#8211; Swiss pharmaceutical company \u200bRoche (ROG.S), opens new tab is aiming \u200cfor a double-digit&hellip;\n","protected":false},"author":2,"featured_media":95437,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[15523,15524,15513,15528,18220,32316,2082,10873,15525,15514,2228,18215,15515,32317,15517,15518,15519,15521,134,32314,10872],"class_list":["post-95436","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-ceeu","tag-ch","tag-cmpny","tag-destoukbsm","tag-destoushem","tag-dk","tag-emea","tag-europ","tag-fin","tag-gdy1","tag-gen","tag-hea","tag-heca","tag-nord","tag-phar","tag-phar1","tag-phmr","tag-publ","tag-roche","tag-scandv","tag-weu"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116845864897903804","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/95436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=95436"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/95436\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/95437"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=95436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=95436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=95436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}